现在位置：百拇书刊 > 国外期刊 > 肿瘤与内分泌 > 2005年.第4期 《肿瘤与内分泌》.2005年.第4期  * Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition  * A single-gene biomarker identifies breast cancers associated with immature cell type and short duration of prior breastfeeding  * Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer  * Tamoxifen treatment for breast cancer enforces a distinct gene-expression profile on the human endometrium: an exploratory study  * The anti-oestrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF-7 breast cancer cells refractory to long-term oestrogen depriv  * No mutations but an increased frequency of SDHx polymorphisms in patients with sporadic and familial medullary thyroid carcinoma  * Targeted cytotoxic bombesin analog AN-215 effectively inhibits experimental human breast cancers with a low induction of multi-drug resistan  * Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines  * Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma  * The p53-homologue p63 may promote thyroid cancer progression  * Increased risk of ovarian cancer in integrin 3 Leu33Pro homozygotes  * Disappearance of a virilizing adrenal tumor following therapy with cyproterone acetate  * Activity and function of the nuclear factor kappaB pathway in human parathyroid tumors  * Association of polymorphisms and haplotypes in the human growth hormone 1 (GH1) gene with breast cancer  * Methylation of estrogen receptor promoter correlates with loss of ER- expression in mammary carcinoma and is an early indication marker in  * Differential expression of IGF-binding protein-3 in normal and malignant colon and its influence on apoptosis  * Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms  * Estrogen receptor- mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen  * Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review  * Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines  * High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosom  * Expression of early placenta insulin-like growth factor in breast cancer cells provides an autocrine loop that predominantly enhances invasi  * Cellular prostatic acid phosphatase: a protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancer  * Emerging role of the endothelin axis in ovarian tumor progression  * Mouse models of transforming growth factor impact in breast development and cancer  * Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer  * Sex steroid-producing enzymes in human breast cancer  * Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues  * Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization